Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
1.910
-0.030 (-1.55%)
Mar 31, 2025, 9:51 AM EDT - Market open
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of $169.04 million as of March 31, 2025. Its market cap has decreased by -11.85% in one year.
Market Cap
169.04M
Enterprise Value
115.12M
1-Year Change
-11.85%
Ranking
Category
Stock Price
$1.91
Market Cap Chart
Since April 25, 2013, Innate Pharma's market cap has increased from $125.22M to $169.04M, an increase of 35.00%. That is a compound annual growth rate of 2.55%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |